Mediwound Ltd (MDWD) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.52
• Market Cap: $223.97M
• EPS: $-1.84
• 52-Week High: $22.50
• 52-Week Low: $14.14

Market Sentiment

Mediwound Ltd currently has a Neutral sentiment score of -0.02.

About Mediwound Ltd

MediWound Ltd. is a leading biopharmaceutical company based in Yavne, Israel, dedicated to developing and commercializing innovative biotherapeutic solutions for tissue repair and regeneration. The company’s flagship product, NexoBrid, represents a transformative advance in burn treatment, underscoring its commitment to fulfilling unmet medical needs within the wound care sector. With a strategic focus on pioneering therapies and the potential for significant growth in the dynamically evolvin...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Mediwound Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MDWD pay dividends?

Mediwound Ltd (MDWD) does not currently pay a regular dividend.

What is MDWD's market cap?

Mediwound Ltd (MDWD) has a market capitalization of $223.97M with a current stock price of $17.52.